Commodore Capital LP 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Commodore Capital LP | 700,000 2.300% |
-185,741 (-20.97%) |
Filing |
| 2023-10-12 4:05 pm Purchase |
2023-10-02 | 13G | Soleno Therapeutics, Inc. SLNO |
Commodore Capital LP | 885,741 6.000% |
885,741 (New Position) |
Filing |